UBS Group AG

SEC CIK: 0001610520
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

GNCA holding history

Genocea Biosciences, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GNCA overview All 13F holders of GNCA Full Q2 2026 holdings

Shares (Q1 2022): 0; Sold out in Q1 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2021

Holdings of GNCA by UBS Group AG, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2022	0	$0	0.0%	−1,129−100.0%	Sold out	Holders
Q4 2021	1,129	$1.00K	<0.1%	+1,129	New	Holders
Q3 2021	0	$0	0.0%	−3,834−100.0%	Sold out	Holders
Q2 2021	3,834	$9.00K	<0.1%	+3,834	New	Holders